Dual specific CD19/CD22-targeted chimeric antigen receptor T-cell therapy for refractory diffuse large B-cell lymphoma: A case report

por Huang, Chen, Zhang, Hui-Chao, Ho, Jin-Yuan, Liu, Rui-Xia, Wang, Lin, Kuang, Na, Zheng, Mei-Rong, Liu, Li-Hong, Li, Jian-Qiang
Publicado 2020